Development and Usability Testing of a Patient Decision Aid for Patients With Inflammatory Bowel Disease Using a Discrete Choice Experiment as Value Clarification Exercise

Author(s)

Schoefs E1, Vandebroek M2, Sabino J3, Verstockt B3, Ferrante M3, Debrun L3, Lambrechts T3, Michiels L4, Lenaerts S1, Van Aerschot A1, Van Audenhove C5, Straetemans N6, Vermeire S3, Huys I1
1Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium, 2Faculty of Economics and Business, KU Leuven, Leuven, Belgium, 3Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, Belgium, 4Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, VBR, Belgium, 5Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium, 6Department of Gastroenterology, az Vesalius, Tongeren, Belgium

OBJECTIVES: To support patient involvement and shared decision making (SDM) for treatment choices in inflammatory bowel disease (IBD), this study aimed to develop and test a patient decision aid (PtDA).

METHODS: A multi-phase study was conducted to develop and test I(BD) SELECT using approaches recommended by the International Patient Decision Aid Standards Collaboration: 1) scope and content determination using semi-structured interviews with IBD patients (n=15) and healthcare professionals (HCPs) (n=23), 2) prototype PtDA development based on clinical guidance, and 3) iterative alpha testing of the prototype PtDA with IBD patients (n=17) and HCPs (n=18). Qualitative data was analyzed thematically. Patients, an IBD nurse, gastroenterologists, a patient organization representative, an SDM expert, and a discrete choice experiment (DCE) expert were involved as researchers throughout the study.

RESULTS: Based on the interviews, we included the choice between different biologicals and small molecules as the options in the PtDA. A web-based prototype PtDA was created including 20 DCE questions as the value clarification exercise. Further, the PtDA was programmed to generate a personal report including patients’ preferences as revealed in the DCE questions next to patients remarks and clinical characteristics (self-reported). Alpha testing showed a mean System Usability Scale score of 78.94/100. Generally, participants had positive feedback about the lay-out, content, and quality of the PtDA but believed several adjustments were needed to improve the user-friendliness (e.g. minimizing complex medical vocabulary) and content (e.g. adding certain information in the educational component). Most participants wanted to use the PtDA in practice.

CONCLUSIONS: I(BD) SELECT received positive feedback from stakeholders during alpha testing, highlighting its potential to facilitate SDM and empower IBD patients to be active participants in the decision-making process. Further refinement through beta testing will optimize usability and effectiveness before broader implementation.

Conference/Value in Health Info

2024-11, ISPOR Europe 2024, Barcelona, Spain

Value in Health, Volume 27, Issue 12, S2 (December 2024)

Code

PCR85

Topic

Patient-Centered Research

Topic Subcategory

Patient Engagement

Disease

Gastrointestinal Disorders, No Additional Disease & Conditions/Specialized Treatment Areas

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×